Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept & continue
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
myFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • Americas
    • Middle East and North Africa
    Most Read
    • Italy blocks shipment of Oxford/AstraZeneca vaccines to Australia
    • Rishi Sunak delivers spend now, tax later Budget to kickstart UK economy
    • Tensions between EU and UK inflamed over Northern Ireland
    • Strong T-cell response is good news for battle against Covid variants
    • Stark link between obesity and Covid deaths revealed
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Yuval Noah Harari: Lessons from a year of Covid | Free to read
    • Hedge funds cash in on the ‘great reflation trade’
    • US tech stocks fall as government bond sell-off resumes
    • Powell inflation comments send US stocks and bonds lower
    • US vs China: Biden bets on alliances to push back against Beijing
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Greensill’s demise shines spotlight on government ties
    • Nikola dropped claim on truck weight after US investigations began
    • German regulator files criminal complaint against Greensill Bank
    • Amazon opens first physical store outside North America
    • Greensill Capital prepares to file for insolvency
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    Most Read
    • Coronavirus: Alabama joins US states lifting mask mandates — as it happened
    • Hedge funds cash in on the ‘great reflation trade’
    • US government bond decline resumes after Fed’s Jay Powell speaks
    • US Treasury bond wobble heightens concerns over health of $21tn market
    • Asian stocks fall as inflation worries stalk markets
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
    Most Read
    • Leavers will forever blame Brussels for Brexit’s failure
    • Bitcoin 1.0: the ancient stone money of Yap
    • The UK’s ‘new Tory’ economics are different but insufficient
    • Sunak’s tax freezes are not as harmless as they seem
    • The insurance call that toppled Greensill
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • Should I reveal I have a difficult boss when interviewing for jobs?
    • The scourge of work email is far worse than you think
    • Ideas flow as an orchestra and school team up
    • FT business books: March edition
    • Negotiation skills prove their real-world worth
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Yuval Noah Harari: Lessons from a year of Covid | Free to read
    • In Rome, a 2,000-year-old emperor’s tomb finally reopens
    • First Brexit, then Covid: can Eurostar get back on track?
    • Bitcoin 1.0: the ancient stone money of Yap
    • Six films to watch this week
  • How to Spend It
  • Sign In
  • Subscribe
MenuSearch
  • Home
  • World
  • US
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • How to Spend It
Financial Times
  • Sign In
  • Subscribe

$50 for your first 3 months Get the print edition and steer from crisis to recovery

Subscribe now

Disease control and prevention

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Thursday, 4 March, 2021
    Coronavirus pandemic
    Coronavirus: Alabama joins US states lifting mask mandates — as it happened
  • Thursday, 4 March, 2021
    Covid-19 vaccines
    Germany approves AstraZeneca jab for over-65s

    U-turn could help speed up the country’s sluggish Covid-19 vaccination campaign

  • Thursday, 4 March, 2021
    Covid-19 vaccines
    Italy blocks shipment of Oxford/AstraZeneca vaccines to Australia

    Intervention threatens to increase global tensions over procurement of Covid jabs

  • Thursday, 4 March, 2021
    US employment
    New US jobless claims bump higher to 745,000

    Pace of lay-offs remains stubbornly high despite some easing of coronavirus curbs

  • Thursday, 4 March, 2021
    Coronavirus treatment
    No need for lengthy trials of vaccine modifications, UK regulator says

    Decision makes approval possible in as little as two weeks after final data is received from manufacturers

  • Thursday, 4 March, 2021
    Deutsche Lufthansa AG
    Lufthansa slumps to worst-ever annual loss

    German airline group flew 76% fewer passengers in 2020 and is burning €300m per month

  • Thursday, 4 March, 2021
    Brussels Briefing
    Brussels’ Covid travel pass runs into early turbulence Premium

    Governments divided over merits of pandemic passports as non-EU vaccines administered in the bloc

  • Wednesday, 3 March, 2021
    Coronavirus pandemic
    Stark link between obesity and Covid deaths revealed

    WHO-backed report concludes that 9 out of 10 fatalities have occurred in countries with high obesity levels

  • Wednesday, 3 March, 2021
    Private equity
    Permira bids for $3.7bn medical device maker LivaNova

    Buyout group’s approach comes as private equity makes a push for healthcare deals amid pandemic

  • Promoted Content
  • Wednesday, 3 March, 2021
    Coronavirus pandemic
    Coronavirus: Biden criticises Texas, Mississippi for ending mask mandates — as it happened
  • Wednesday, 3 March, 2021
    Covid-19 vaccines
    Chinese and South African police seize fake Covid vaccines

    Criminal gangs seek to capitalise on global demand for coronavirus jabs

  • Wednesday, 3 March, 2021
    Coronavirus treatment
    Strong T-cell response is good news for battle against Covid variants

    US study likely to alleviate some concerns about new strains outsmarting vaccines

  • Wednesday, 3 March, 2021
    David Pilling
    Pandemics and the paradox of human progress

    The more we destabilise the planet in the name of advancement, the more pathogens will emerge

  • Wednesday, 3 March, 2021
    The FT ViewThe editorial board
    The EU’s vaccination rollout badly needs a revamp

    Laggards can learn from more ambitious members of the bloc

  • Wednesday, 3 March, 2021
    US-China relations
    US and Asia allies plan Covid vaccine strategy to counter China

    Biden administration in talks with Japan, India and Australia to distribute jabs across region

  • Wednesday, 3 March, 2021
    Cuba
    Cuba starts final-stage trials of two homegrown Covid vaccines

    Soberana 2 and Abdala jabs reported to show ‘potent immunological response’ in earlier trials

  • Wednesday, 3 March, 2021
    News in-depthCovid-19 vaccines
    Tempers fray over France’s vaccine strategy

    Emmanuel Macron’s government under fire for handling of jabs and lockdowns

  • Wednesday, 3 March, 2021
    FT News Briefing podcast9 min listen
    Biden’s vaccine deal, Ant’s troubles, Germany’s vaccine rollout

    Partnership between top drugmakers to provide Covid-19 vaccines for every adult American by May

  • Wednesday, 3 March, 2021
    Australia
    Iron ore and household spending stoke rapid rise in Australia GDP

    Successful campaign to rein in Covid-19 infections helped economy grow 3.1% in fourth quarter

  • Tuesday, 2 March, 2021
    Coronavirus pandemic
    Texas lifts mask mandate as US states loosen Covid restrictions

    Actions follow Biden administration warnings against rolling back pandemic rules too quickly

  • Tuesday, 2 March, 2021
    Coronavirus pandemic
    Coronavirus: Lyft records busiest week since before pandemic — as it happened
  • Tuesday, 2 March, 2021
    Covid-19 vaccines
    Biden says US will have enough jabs to vaccinate all adults by end of May

    White House announces accelerated timeline after brokering production deal between J&J and Merck

  • Tuesday, 2 March, 2021
    Covid-19 vaccines
    Covid vaccines show few serious side-effects after millions of jabs

    Surveillance of AstraZeneca and Pfizer recipients in UK reports minor complaints but few severe reactions

  • Tuesday, 2 March, 2021
    Coronavirus pandemic
    WHO investigators deeply sceptical of China’s Covid origin theory

    Members of Wuhan team say authorities’ claim virus entered city on frozen food highly unlikely

  • Tuesday, 2 March, 2021
    The Big Read
    Redemption shot: von der Leyen begins fightback on EU vaccine rollout

    With Europe facing a possible third wave and public doubts about efficacy, the commission president is under pressure from member states

Previous You are on page 1 Next

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

FT LiveShare News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingContracts & Tenders
Executive Job SearchAdvertise with the FTFollow the FT on TwitterFT TransactSecondary Schools

Tools

PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School Rankings
Enterprise ToolsNews feedNewslettersCurrency Converter
More from the FT Group
Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2021. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

International Edition

  • Switch to UK Edition
  • Top sections
  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • Americas
    • Middle East and North Africa
  • US
    • US Economy
    • US Companies
    • US Politics & Policy
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • How to Spend It
  • Special Reports
  • FT recommends
  • Graphics
  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • FTfm
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • myFT
  • Portfolio
  • Today's Newspaper (ePaper)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In